Recorded Chinese product: 复方乳酸钠山梨醇注射液复方乳酸钠山梨醇注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 陕西济生制药有限公司Chinese legal name: 陕西济生制药有限公司
主要成分Active Ingredients
- 山梨醇Shanli Chun
- 氯化钠Lvhua Na
- 氯化钾Lvhua Jia
- 氯化钙Lvhua Gai
药物知识说明
山梨醇是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括：山梨醇Shanli Chun、氯化钙Lvhua Gai、氯化钠Lvhua Na、氯化钾Lvhua Jia。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品：山梨醇-8c569e7f成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 复方乳酸钠山梨醇注射液) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 山梨醇Shanli Chun, 氯化钙Lvhua Gai, 氯化钠Lvhua Na, 氯化钾Lvhua Jia.
Explore other medicines containing the same ingredient: 山梨醇 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 复方乳酸钠山梨醇注射液Recorded Chinese product: 复方乳酸钠山梨醇注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 500ml500 mL
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 陕西济生制药有限公司Chinese legal name: 陕西济生制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20063705
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20063705
Manufacturer
Chinese legal name: 陕西济生制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20063705
生产企业
陕西济生制药有限公司(国产)
适应症
调节体液、电解质及酸碱平衡药。作为体液补充药。用于代谢性酸中毒或有代谢性酸中毒并需要补充热量的脱水病例。本品尤适用于糖尿病患者。
用法用量
静脉滴注 成人一次500ml～1000ml，按年龄、体重及症状不同可适当增减。给药速度：成人每小时300~500ml。
不良反应
快速大量给药时，可能出现肺水肿、脑水肿、肢体水肿。
禁忌
乳酸血症患者及高钾血症、少尿、阿狄森病、重症烧伤、高氮血症及遗传性果糖不耐症患者禁用。
注意事项
肾功能不全、心功能不全、重症肝功能障碍、因阻塞性尿路疾病引起尿量减少的患者慎用。用药时根据临床需要可作下列检查及观察1．血气分析或血二氧化碳结合力检查。2．血清钠、钾、钙、氯浓度测定。3．肾功能测定，包括血尿素氮、肌酐等。4．血压。5．心肺功能状态，如浮肿、气急、紫绀、肺部音、颈静脉充盈，肝-颈静脉返流等，按需作静脉压或中心静脉压测定。6．肝功能不全表现，如黄疸、神志改变、腹水等。应严格按照需要用药，防止体液形成新的不平衡。注意给药速度不能过快。使用前应仔细检查溶液是否浑浊、絮状沉淀、异物及瓶盖松动、裂纹等。
贮藏
密闭保存。
规格
500ml
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.